Aytu BioScience Inc (AYTU) Receives a Buy from Northland Securities
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Aytu BioScience Inc (AYTU), with a price target …
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Receives a Buy from Oppenheimer
In a report released today, Esther Rajavelu from Oppenheimer maintained a Buy rating on Biohaven Pharmaceutical Holding Co Ltd (BHVN). The company’s shares …
Oppenheimer Reaffirms Their Buy Rating on Moderna Inc (MRNA)
In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Moderna Inc (MRNA). The company’s shares opened today at …
H.C. Wainwright Thinks Novavax’s Stock is Going to Recover
In a report released today, Vernon Bernardino from H.C.
Oppenheimer Maintains a Buy Rating on Addus Homecare Corp (ADUS)
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Addus Homecare Corp (ADUS) today. The company’s shares opened today at $66.
Analysts Conflicted on These Healthcare Names: Vascular Biogenics (VBLT) and Zogenix (ZGNX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Vascular Biogenics (VBLT) and Zogenix (ZGNX). …
Oppenheimer Believes Chemed (CHE) Still Has Room to Grow
In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Chemed (CHE). The company’s shares closed yesterday at $328.
Morgan Stanley Keeps Their Hold Rating on Splunk Inc (SPLK)
Morgan Stanley analyst Melissa Franchi maintained a Hold rating on Splunk Inc (SPLK) today and set a price target of $140. The company’s …
Merrill Lynch Believes Stoneco Ltd (STNE) Won’t Stop Here
Merrill Lynch analyst Mario Pierry maintained a Buy rating on Stoneco Ltd (STNE) today and set a price target of $42. The company’s …
Inmune Bio Inc (INMB) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Inmune Bio Inc (INMB) today and set a price target of …